Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Would you consider eliminating post lumpectomy RT in a premenopausal patient with pCR after chemotherapy for a cT1cN0 triple negative breast cancer?
Answer from: Radiation Oncologist at Community Practice
We don't have any prospective data on omitting RT in this case and would not consider this approach for triple negative patients.
Sign in or Register to read more
12900
Related Questions
What is your preferred method of surveillance after mastectomy?
How are you clinically incorporating the data presented from RT Charm at ASTRO 2024?
What is your treatment approach in patients with early breast cancer with axillary soft tissue involvement, with or without concurrent lymph node involvement?
Would you omit radiation for an elderly woman with bilateral breast cancers (both early-stage disease and ER+/PR+/HER2 negative) who otherwise meets the criteria for endocrine therapy alone?
Is there any contraindication for a patient receiving omalizumab for treatment of her lung aspergillosis to receive adjuvant breast radiotherapy?
Do you consider chest wall constraints when treating with 5-fraction APBI?
When treating APBI with the Florence regimen, are you using daily or every other day fractionation?
Does radiation therapy (ex. to the breast) in patients with CDK4 mutations increase the risk of developing melanoma?
In a patient with cardiac comorbidities, who meets ASTRO APBI criteria other than a positive margin, would you offer APBI in an attempt to reduce cardiac dose?
What is the current paradigm for breast cancer diagnosed with isolated metastases prior to initial treatment?